Christine S
New Member
I'm looking for something other that bactrostatic water for Cagrilintide. The agent needs to have a ph of 4. Any suggestions?
I have checked the ph. twice now and it's at 6 after being reconstituted. I have heard that it is still good for about a month, but any longer than that can actually cause health problems?Unfortunately the pH of whatever is being used to reconstitute cag is not necessarily going to have the desired effect depending on what buffers may have been used to control pH prior to lyophilization. Best bet is to use BAC, test the pH, and then try to adjust as necessary with acetic acid. Depending on who produced it, it may reconstitute to the proper pH without any problem.
The comments in the thread are actually giving me pause. I bought a cheap cagri kit but I didn't realize there's a possibility of the pH making it harmful. Maybe I'll stick to the GLPs
I had this exact same concern and question based on the research I did. It was a bunch of complex and abstract stuff and I’m not a chemist so but I arrived with the same question basically about the fibrils. Again I’m not qualified to answer it. Would be pretty crazy though if just 2 PH degree difference would be this crucial to risk Alzheimer’s. Kinda makes the entire drug seem sketchy regardless lol.PREMISE 2: When fibrils are injected SQ, it will find its way all over your body such as your brain tissue. PREMISE 3: The fibrils that are deposited in the brain tissue cause Alzheimer's. In short, the concern was: going from premise 1 to premise 3, if you reconstitute your Cagri at pH above 4, are you putting yourself at high risk for Alzheimer's? This is what I have been researching
"There are several differences in the peptide structure of cagrilintide compared to pramlintide. The proline substitutions (Pro25, Pro28, and Pro29) in cagrilintide suppress the development of amyloid fibrils. Furthermore, the Tyr37 Pro substitution boosts efficacy. The peptide also contains two substitutions: Asn14 Glu, which prevents deamination, and Val17 Arg, which increases solubility at physiological pH and forms a helix-stabilizing salt bridge with Glu14. Additionally, the attachment of a C-20 fatty diacid via α-glutamyl spacer increases the duration of action by binding to albumin. A summary of the available studies of cagrilintide treatment in patients with diabesity is presented in Table 2."
Agree. I cannot find anything yet other than threads/links in subreds. I woukd think NEJM might have a study or Nature- but would need a research ‘.edu’ email domain to search/review. Google Scholar is a good place to start for search/ journal pubs.Need someone taking Cagril with an actual chemistry / biomedical background to look into all this and interpret these findings. It’s over my head.